Clinical characteristics and temporal trends of meropenem and piperacillin/tazobactam heteroresistance in Pseudomonas aeruginosa isolates
Yali Fan, Huilan Li, Xiaoyue Liang, Jia Xie, Biyu Lin, Zheng Liang, Weifeng Liu, QinJin Wang, Tian Zhong, Ying Chen, Shuping Nie, Chao Wu · 2026
Read Clinical characteristics and temporal trends of meropenem and piperacillin/tazobactam heteroresistance in Pseudomonas aeruginosa isolates by Yali Fan, Huilan Li, Xiaoyue Liang, Jia Xie, Biyu Lin, Zheng Liang, Weifeng Liu, QinJin Wang, Tian Zhong, Ying Chen, Shuping Nie, Chao Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13584257.txt.
Description
Yali Fan and colleagues report a 2026 study of hidden drug resistance in Pseudomonas aeruginosa, a germ that often infects hospital patients. In heteroresistance, most of a strain falls to an antibiotic while a small hardy share survives, which can sink treatment without warning. The team tested 380 clinical strains from one large hospital, collected between 2011 and 2024, against two widely used drugs.
Careful follow-up tests confirmed the hidden pattern in about half the strains for at least one of the two drugs. Rates for both drugs peaked in the years 2017 to 2019, then fell back during the pandemic years. Past use of one antibiotic family raised the odds of the pattern, while being male or having prior antiviral treatment lowered them. The authors suggest routine screening for high-risk patients.
Catalog record
| CREATOR | Yali Fan, Huilan Li, Xiaoyue Liang, Jia Xie, Biyu Lin, Zheng Liang, Weifeng Liu, QinJin Wang, Tian Zhong, Ying Chen, Shuping Nie, Chao Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48242 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |